i-Base home
Search Menu
  • Home
  • HTB
  • Conference reports
  • 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA

45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA

10 February 2006. Related: Conference reports, ICAAC 45th Washingon 2005, Conference index.

Reports from the conference.

  • Understanding TMC114 power against resistant HIV
  • New antiretroviral compounds at ICAAC: new PI brecanavir from GSK; maturation inhibitor PA-457; antiviral activity of monoclonal antibody; TNX-355 in treatment experienced patients
  • Comparison of pharmacokinetics of originator and generic liquid formulations and split tablets in Malawian children
  • African-Americans in ACTG 5095 had shorter time to virologic failure and grade 3/4 side effects
  • Predictors of insulin resistance in first year of therapy
  • Three measures confirm 144-week renal record of tenofovir
  • Low rash risk with efavirenz after nevirapine rash

Abstracts from the ICAAC meeting only remain on the conference website for a few months, and are then only available through subscription.

Links to other websites are current at date of posting but not maintained.

  • HTB RSS
  • Understanding TMC114 power against resistant HIV
  • Mortality trends: why people with HIV die (or don’t) today

Early access

  • Kigala Call to Action: sign-on for IAS 2025 conference 1 July 2025
  • HIV organisations support trans and non-binary communities against the unworkable EHRC guidelines 30 June 2025
  • Long-acting injectable PrEP approved in the US: priced at $28,000 a year 28 June 2025
  • Clinical studies of two once-weekly pipeline compounds put on hold 27 June 2025
  • All early access reports

Current issues

  • July 2025
  • June 2025
  • May 2025
  • Back issues

Special report

  • Kigala Call to Action: sign-on for IAS 2025 conference 1 July 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook